Researchers are exploring various methods to target and degrade proteins previously considered "undruggable" that are associated with diseases such as cancer and dementia. These approaches include using CRISPR enzymes, nanoparticles, molecular glues, and protein degraders, as well as designing peptides with the help of artificial intelligence. The goal of these efforts is to develop new treatments that can effectively target and destroy these problematic proteins.